Drs. Ibilibor and Stratton preview research from the 2022 Genitourinary Cancers Symposium.
EP. 1: 2022 ASCO GU Overview: Dr. Ibilibor on metastatic UC, RCC, and rare cancers
Christine Ibilibor, MD, discusses 6 noteworthy abstracts from the 2022 Genitourinary Cancers Symposium.
EP. 2: 2022 ASCO GU Overview: Dr. Stratton highlights top prostate cancer abstracts
Kelly L. Stratton, MD, FACS, highlights 5 pivotal prostate cancer studies from the 2022 ASCO Genitourinary Cancers Symposium.
CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC
Is there a difference between MD and DO in urology?
64Cu-SAR-Bombesin shows efficacy in detecting prostate cancer recurrence
From prep to follow-up: Key considerations for administering onabotulinumtoxinA
